Overview

Subcutaneous Injection of Large Volumes of Tumescent Lidocaine and Epinephrine by Laypersons

Status:
Not yet recruiting
Trial end date:
2021-06-07
Target enrollment:
Participant gender:
Summary
This research is intended to show that it is safe and not difficult for nearly anyone to inject at least 125ml of a dilute solution of tumescent lidocaine and epinephrine (TLE), where a TLE solution consists of lidocaine (1gm/L) and epinephrine (1mg/L) in normal saline.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Jeffrey Alan Klein, MD
Treatments:
Epinephrine
Lidocaine